TerrAscend Stock (CSE: TER) (OTC: TRSSF) - Investor Dashboard

➔ TerrAscend
CSE Ticker: TER
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 20
Established: 2014
CEO: Dr. Michael Nashat

TerrAscend – Cannabis Facilities

Solace Health operates a purpose-built facility led by an experienced cultivation team that grows medical grade, pesticide free cannabis for Canadian patients.

  • Licensed to cultivate medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”)
  • 6,350 sq. ft. completed and operational, including 4,000 sq. ft. of flowering space, with expansion space up to 26,000 sq. ft. of total cultivation space
  • Capacity to produce 600+ kilograms of dried cannabis per year, with expansion capacity up to 4,000 kilograms annually
    1,500 sq. ft. vault built with Level 10 specifications
  • Experienced cultivation team leading the design & operation of facility

Visit TerrAscend, Inc.
at www.terrascend.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. TerrAscend, Inc. is a client of NCV Media, LLC. Read our full disclaimer.